On the forefront in the fight against COVID-19
The fight against SARS-CoV-2 can be conducted on different levels. Alcedis is currently participating in three clinical studies on coronavirus infection.
The future of medicine is based on intensive research. Innovations from genetic research and digitization, for example, are revolutionizing medicine and healthcare more than ever before. Strong entrepreneurs are also needed to turn scientists‘ results into real products and help to improve patients’ diagnosis, prevention, therapy, nursing and rehabilitation. These stories provide insights into the top research and development in central Hessen and show the latest trends – always for the benefit of patients all over the world.
The fight against SARS-CoV-2 can be conducted on different levels. Alcedis is currently participating in three clinical studies on coronavirus infection.
Good medicine needs secure financing: The medService of Volksbank Mittelhessen offers doctors, pharmacies and clinics tailor-made financing for investments, devices and office equipment.
Giessen dermatologist and professor Dr. Peter Mayser has succeeded in developing a natural anti-dandruff agent in collaboration with Symrise AG, which is being marketed under the name Crinipan® PMC green.
A research team from the University of Marburg has successfully used the cancer drug ruxolitinib to treat a 65-year-old female patient suffering from acute lung failure after coronavirus infection.
Respiratory masks play an important role in containing the corona pandemic. But time and time again, faulty masks end up on the market. Specialists from weisstechnik improve safety with their mask testing technology.
A research team from Central Hessen is testing a new strategy in the fight against corona: a substance that inhibits a cell’s own enzyme and thus reduces the reproduction of different viruses.
Medical experts already agree that coronavirus can also affect other organs such as the heart and kidneys – as well as the central nervous system. However, there is no reliable evidence for the exact pathomechanism. To clarify this, a nationwide register is currently being set up at the University of Giessen.
A vaccine against SARS-CoV-2 is the saving anchor for millions of people. Healthcare experts from Central Hessen have again come a step closer to this goal. Clinical trials on humans can begin.